The levetiracetam active pharmaceutical ingredient (API) market is driven by its use as a widely prescribed antiepileptic drug [1]. Levetiracetam is marketed under various brand names, including Keppra, and is also available as a generic medication [2].
How is Levetiracetam Used in Medicine?
Levetiracetam is approved to treat partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures in adults and children [3]. It works by affecting the release of certain neurotransmitters in the brain, which helps to prevent seizures [4].
What is the Status of Levetiracetam Patents?
The original patents for levetiracetam have expired in many regions, paving the way for generic competition [5]. However, specific formulations or manufacturing processes might still be protected by patents. Information on patent expiry dates and active patents can be found on DrugPatentWatch.com [5].
Who are the Major Manufacturers of Levetiracetam API?
Several pharmaceutical companies manufacture and supply levetiracetam API globally. The market includes both originator companies that developed the drug and numerous generic API manufacturers [1]. Identifying specific manufacturers often requires looking at supplier directories and regulatory filings.
What is the Market Size and Growth Potential for Levetiracetam API?
The market for levetiracetam API is substantial due to its broad clinical application and the availability of generic versions. Market growth is influenced by factors such as the prevalence of epilepsy, healthcare access, and pricing of generic drugs [1]. While exact market size figures vary by report, the generic nature of levetiracetam suggests a competitive pricing environment [2].
What are the Alternatives to Levetiracetam?
Numerous other antiepileptic drugs are available, including valproic acid, carbamazepine, lamotrigine, and lacosamide, among others [4]. The choice of medication depends on the type of seizure, patient age, other medical conditions, and potential side effects [3].
What is the Regulatory Landscape for Levetiracetam API?
Levetiracetam API must meet strict quality and purity standards set by regulatory agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [6]. Manufacturers must adhere to Good Manufacturing Practices (GMP) to ensure the safety and efficacy of the API [6].
---
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/
5. https://www.drugpatentwatch.com/
6. https://www.drugpatentwatch.com/